A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies. [PDF]
Tsukamoto Y +6 more
europepmc +1 more source
A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy. [PDF]
Li HX +4 more
europepmc +1 more source
From Activated Partial Thromboplastin Time to Antifactor Xa and Back Again. [PDF]
May JE +4 more
europepmc +1 more source
Impact of Heparin Hemodialysis Catheter Lock on Partial Thromboplastin Time Assays in Inpatients on Therapeutic Intravenous Heparin. [PDF]
Tuggle TS, Noureddine L, Hobbs RA.
europepmc +1 more source
Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population. [PDF]
Zhang F +11 more
europepmc +1 more source
Deep learning model for screening causes of activated partial thromboplastin time prolongation using clot waveform analysis at multiple wavelengths. [PDF]
Matsuda M +10 more
europepmc +1 more source
Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis. [PDF]
Kato K +4 more
europepmc +1 more source
A Case of Severe Prekallikrein Deficiency Manifesting as Isolated Activated Partial Thromboplastin Time (aPTT) Prolongation. [PDF]
Viswanathan D, Sivanandam A, Yeung V.
europepmc +1 more source
Algorithm-based effective recognition of acquired hemophilia A and other causes of isolated prolonged activated partial thromboplastin time within large blood sample series. [PDF]
Turincev P +5 more
europepmc +1 more source

